semaglutide compound ending Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots FDA sets tirzepatide compounding deadlines

The most important sub-groups reviewed include abnormal metabolic obesity, normal metabolic obesity, abnormal metabolic weight, normal metabolic weight, and sarcopenic obesity (3)

Comparing sulfur burp management across different GLP-1 medications If sulfur burps are severe and persistent despite all management strategies, switching between GLP-1 medications is sometimes worth considering

In SURMOUNT-1, published in NEJM in 2022, tirzepatide at the 15 mg weekly dose produced a mean placebo-adjusted body weight reduction of 17.8% at 72 weeks in adults with obesity (Jastreboff et al., NEJM, 2022)

This is why meal composition matters as much as meal size for GLP-1 production